Clinical trial

The MIND-GUT Digital Pilot Intervention Study

Opening soon · Not applicable · 1 countries · Registry ID NCT06374407

Opening soonNot applicableInterventional

What this study is about

This 12-week pilot study aims to evaluate the feasibility and effectiveness of a dietary intervention targeting diet, obesity, mental health, and the gut microbiome in promoting weight loss and enhancing mental health among obese men and women aged 30-50. Participants, excluding those with specific medical conditions, will be randomly assigned to either an intervention or control group using a meal planning smartphone app. Clinical assessments will include anthropometry, mental health questionnaires, dietary recalls, and stool sample collections. The study's endpoints include program retention, adherence, changes in body weight, mental health, and gut microbiome diversity. Statistical analyses will evaluate intervention effects and the potential mediating roles of the gut microbiome. This pilot study has implications for health policies, public healthcare, digital health companies, and the biotech and pharmacology industries. Future plans involve a large-scale intervention study in multiple countries with ongoing collaborations.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age30 Years to 50 Years
SexAll
Healthy volunteersAccepted
ConditionObesity, Depressive Symptoms, Anxiety, Stress, Eating Habit, Dysbiosis

Full registry criteria

Inclusion Criteria: * age 30- 50; * BMI ≥ 30 kg/m2; * stable physical activity; * one person per household; * commitment to full protocol. Exclusion Criteria: * use of psychiatric medications (e.g., serotonin reuptake inhibitors); * use of weight loss medications (GLP-1 receptor agonists); * food allergies affecting adherence to the MIND diet; * diagnosis of eating disorders; * diagnosis of diabetes; * diagnosis of polycystic ovary syndrome; * sensory deficits (e.g., COVID-19-induced loss of taste/smell); * antibiotic use during the latest 3 months; * participation in another study; * language understanding limitations (i.e., not able to understand either Swedish or English); - coeliac/inflammatory bowel disease; * planned weight management program within three months; * pregnancy; * lactation; * menopause.

Treatments and study arms

Dietary intervention based on the MIND diet

Behavioral

A 12-week pilot randomized controlled trial (RCT) involving N=126 obese participants (1:1 gender ratio) to assess protocol feasibility, including recruitment, retention, compliance, physical examinations, and gut sample collection. Sample size, calculated by a statistician, expects a 5% body weight change at follow-up (std. dev. 10%). We chose a 12-week duration for this pilot study to allow sufficient time to observe significant changes in both body weight and mental health.

Primary outcomes

Program retention12 weeks

Evaluation of participants' continued engagement in the program over time i.e., % of individuals completing the second and third 24h diet recall and % of participants returning to the second visit at the end of the intervention.

Adherence12 weeks

Measurement of participants' compliance with the assigned diet and program through 24h recall interviews, assessed comparing reported intake frequencies of each food group with the recommended intake frequencies according to the principles of the MIND diet.

Acceptability12 weeks

Assessment of participants' experience of the program through qualitative interviews, focusing in particular on: Perception of and experience with the intervention, intervention components (dietary plans, use of the app, etc.), factors influencing participants' engagement, perceived impact on behavior and well-being, interaction with the staff, suggestions for improvement.

Study effectiveness: change in eating attitudes at follow-up12 weeks

Comparison of a score calculated after administration of the EAT-26 questionnaire at baseline vs. follow-up. The EAT-26 comprises three subscales, namely, Dieting, Bulimia and Food Preoccupation, and Oral Control. Higher scores correspond to a worse outcome.

Study effectiveness: change in stress levels at follow-up12 weeks

Comparison of PSS-4 questionnaire at baseline vs. follow-up. The PSS total score is calculated by reverse-coding the positive items and summing the scores for all items. The total scores range from 0 to 56, from 0 to 40, and from 0 to 16 for the PSS-14, PSS-10, and PSS-4, respectively. A higher score indicates more perceived stress.

Study effectiveness: change in depression symptoms at follow-up12 weeks

Comparison of PHQ-9 questionnaire at baseline vs. follow-up. The PHQ-9 is a tool to assist clinicians in identifying and diagnosing major depression. It has a maximum score of 27. Higher scores correspond to worst outcomes in terms of depression symtoms.

Study effectiveness: change in anxiety symtoms at follow-up12 weeks

Comparison of GAD-7 questionnaire at baseline vs. follow-up. Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting worst outcomes in terms of anxiety severity.

Study effectiveness: change in body weight at follow-up12 weeks

Comparison of body weight at baseline vs. follow-up

Study locations

1 locations were listed when this page was built. The first 40 are shown.

University of Skövde🇸🇪 Skövde, Sweden
Gianluca Tognon, PhDContact